Table 1.
Clinical characteristics of the studied women
| Clinical Data | Endometrial Cancer | Cervical Cancer | Ovarian Cancer | Group I | Group II |
|---|---|---|---|---|---|
| (N = 42) | (N = 13) | (N = 14) | (N = 20) | (N = 23) | |
| Age (years) | 62.52 ± 9.81; | 48.77 ± 12.94; | 53.21 ± 6.68; | 53.42 ± 14.51; | 42.52 ± 9.18; |
| 61.50 *** | 49.00 | 54.00 *** | 51.50 ** | 45.00 | |
| (44–83) | (27–66) | (40–65) | (24–78) | (25–59) | |
| Gravidity | 2.88 ± 2.20; | 1.54 ± 1.33; | 2.79 ± 2.04; | 2.10 ± 2.40; | Insufficient data |
| 2.50; | 1.00; | 2.50; | 2.00; | ||
| (0–13) | (0–5) | (0–8) | (0–10) | ||
| Parity | 2.69 ± 1.96; | 1.15 ± 0.90; | 2.57 ± 1.74; | 1.85 ± 2.06; | Insufficient data |
| 2.00; | 1.00; | 2.00; | 2.00; | ||
| (0–12) | (0–3) | (0–7) | (0–8) | ||
| Body mass (kg) | 87.13 ± 20.56; | 62.46 ± 11.21; | 65.09 ± 10.21; | 71.30 ± 17.34; | Insufficient data |
| 85.00 | 60.00 | 69.00 | 68.50 | ||
| (45–130) | (46–80) | (48–78) | (47–120) | ||
| Height (cm) | 159.68 ± 6.73; | 160.54 ± 5.56; | 161.43 ± 4.29; | 164.35 ± 5.11; | Insufficient data |
| 160.00 | 162.00 | 160.00 | 164.00 | ||
| (135–172) | (152–172) | (157–170) | (156–174) | ||
| BMI (kg • (m2)-1) | 34.14 ± 7.82; | 24.38 ± 4.99; | 24.97 ± 3.81; | 26.37 ± 6.20; | Insufficient data |
| 31.94 | 22.77 | 26.43 | 24.86 | ||
| (20.31-50.78) | (15.55-33.73) | (18.28-28.92) | (18.83-4.62) | ||
| Percentage of subjects after menopause (%) | 90.48 *** | 46.15 | 71.43 ** | 60.00 * | 26.09 |
Group I - women operated but had no malignancy in postoperative histopathologic examination, Group II - healthy women. BMI - Body Mass Index. Data are shown as: mean ± 1 SD, median (minimum-maximum). Asterisks indicate statistically significant differences in Mann–Whitney U test: * - p < 0.05; ** - p < 0.01; *** - p < 0.001, in comparison to Group II.